Who are Kerafast's investors?

Kerafast's investors include FCA Venture Partners.

How much funding has Kerafast raised?

Kerafast has disclosed $1.4M raised across 3 rounds.

Where is Kerafast headquartered?

Kerafast is headquartered in Boston, US.

Kerafast

Boston, US · Founded 2010 · Delaware corporation · 1 known investors

Kerafast is an online marketplace that distributes laboratory reagents and research materials sourced from academic and research institutions, making individual scientists' unique reagents available to the global research community. It serves life science researchers and connects laboratories that produce specialized reagents with those seeking them.

B2B Marketplaces Biotech E-commerce Healthtech Marketplaces

Founders & leadership

Jennifer RossiExecutive

Robert P BondarykExecutive

William C. EmhiserExecutive

Robert P. BondarykExecutive

Board

Andrew Bouldin inBoard directorPartner at FCA Venture Partners

Matthew A King inBoard directorManaging Partner at FCA Venture Partners

Matthew L. KingBoard director

John E. BurchBoard director

Kim D. WestmorelandBoard director

Kim D WestmorelandBoard director

William EmhiserBoard director

Investors · 1

FCA Venture PartnersNashville · $500K – $10M

Reported raises · per SEC filings

Form D private placements

$1.4M disclosed across 3 rounds · 2012–2016

▶$250KraisedMar 2016 · 1 investors · Other

Rule 506(c)

Officers, directors & promoters on the filing

Kim WestmorelandDirector
Robert P BondarykExecutive Officer, Director
Andrew BouldinDirector
William EmhiserDirector
Matthew KingDirector

Offering amount: $1.1M
Amount sold: $250K
First sale: Mar 2016
Incorporated: Corporation, Delaware
Federal exemptions: 06c

Full filing on SEC EDGAR ↗

▶$634.8KraisedApr 2015 · 11 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Andrew BouldinDirector
Kim D WestmorelandDirector
William EmhiserDirector
Jennifer RossiExecutive Officer
Matthew A KingDirector
Robert P BondarykExecutive Officer, Director

Offering amount: $1M
Amount sold: $634.8K
First sale: Oct 2014
Incorporated: Corporation, Delaware, 2010
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$500KraisedMar 2012 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Matthew L. KingDirector
William C. EmhiserExecutive Officer, Director
John E. BurchDirector
Kim D. WestmorelandDirector
Robert P. BondarykExecutive Officer, Director

Offering amount: $1.5M
Amount sold: $500K
Proceeds to insiders: $12.5K
First sale: Mar 2012
Incorporated: Corporation, Delaware, 2010
Federal exemptions: 06

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Abcam256 shared keywordsSupplier of protein research tools to life scientists. Publicly listed on the LSE following an IPO.

Companies competing with Kerafast for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Kerafast is helping food scientists serve up plant-based meat and more - Boston Business Journalbizjournals.com · Mar 2020

Frequently asked questions

What does Kerafast do?: Kerafast is an online marketplace that distributes laboratory reagents and research materials sourced from academic and research institutions, making individual scientists' unique reagents available to the global research community. It serves life science researchers and connects laboratories that produce specialized reagents with those seeking them.
Who are Kerafast's investors?: Kerafast's investors include FCA Venture Partners.
How much funding has Kerafast raised?: Kerafast has disclosed $1.4M raised across 3 rounds.
Where is Kerafast headquartered?: Kerafast is headquartered in Boston, US.